Monday, April 21, 2008

Targeted alpha therapy

This is something I read about in 2001, and it still seems to be one of the most promising ideas in cancer therapy. The treatment involves two molecular objects bound together. One is an antibody that gets taken into a cancer cell. The other is a radioactive actinium-255 atom which has a ten-day half-life, and then decays through a few different products, releasing four alpha particles, which rip through the cancer cell and kill it. Luckily alpha particles have only enough energy to destroy one cell, and then they run out of steam and become inert helium nuclei.

At Sloan-Kettering where this work was done, they applied for a patent. A clinical trial was conducted in 2002 with favorable results. There have also been some clinical trials in Australia, I believe.

As far as I am aware, this is a fantastic treatment, due to its being extremely specific, and is applicable to a wide range of cancers, but it's not used much. I would imagine the actinium-255 must be prepared through some process that would probably be very expensive. It would be great if some more affordable alternative could be found. It seems to me that were advanced nanotech available today, some suitable replacement for the radioactive actinium nucleus might be possible.


Tom said...
This comment has been removed by the author.
Tom said...


These DNA solids are created by altering the concentration of individual 3-star tiles. It is a little bit different than the origami
techniques. Chengde Mao published on this.